Koshinski Asset Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-15,763
Closed -$10K 291
2019
Q2
$10K Sell
15,763
-2,000
-11% -$1.44K ﹤0.01% 270
2019
Q1
$20 Hold
17,763
0.01% 393
2018
Q4
$8K Hold
17,763
﹤0.01% 400
2018
Q3
$28K Buy
+17,763
New +$23.6K ﹤0.01% 523

Other funds holding CELGZ

Koshinski Asset Management's CELGZ Position: Q3 2019 in Review

Koshinski Asset Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q3 2019, closing a stake of 15,763 shares — an estimated $10K sold.

Koshinski Asset Management first reported a position in CELGZ in Q3 2018 and held it in 4 quarters. The position peaked at $28K in Q3 2018. 24 funds tracked by Wall St. Rank hold CELGZ as of Q3 2019.

  • Koshinski Asset Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q3 2019 after selling out during the quarter.
  • Koshinski Asset Management sold 15,763 Celgene Corporation Contingent Value Rights shares in Q3 2019, an estimated $10K.
  • Koshinski Asset Management first reported a position in Celgene Corporation Contingent Value Rights in Q3 2018 and held it in 4 quarters.
  • Koshinski Asset Management's Celgene Corporation Contingent Value Rights position peaked at $28K in Q3 2018.
  • 24 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q3 2019.

Based on Koshinski Asset Management's 13F filing for Q3 2019, filed 30 Oct 2019.